# Intravenous and Perineural Dexamethasone for Ultrasound-Guided Axillary Blocks

> **NCT02629835** · PHASE2,PHASE3 · COMPLETED · sponsor: **Montreal General Hospital** · enrollment: 150 (actual)

## Conditions studied

- Brachial Plexus Block Duration

## Interventions

- **OTHER:** intravenous 8 mg dexamethasone and perineural 0.8 ml of saline solution
- **OTHER:** intravenous 0,8 ml of saline solution and perineural 8 mg of dexamethasone

## Key facts

- **NCT ID:** NCT02629835
- **Lead sponsor:** Montreal General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2017-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02629835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02629835, "Intravenous and Perineural Dexamethasone for Ultrasound-Guided Axillary Blocks". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02629835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*